Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality

Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality

Background: Delayed hyponatremia after pituitary surgery can be treated with the V2-receptor antagonist, oral tolvaptan. We investigated the pharmacological effect of oral tolvaptan against SIAD in patients with hyponatremia after pituitary surgery. Methods: Thirty-nine patients with pituitary adeno...

Full description

Bibliographic Details
Main Authors: Masahiko Tosaka, Rei Yamaguchi, Yutaro Itabashi, Naoto Mukada, Haruka Tsuneoka, Kentaro Takahashi, Shunsuke Nakamura, Takahiko Nakazawa, Yuhei Yoshimoto
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Heliyon
Subjects:
Tolvaptan
Vasopressin V2-receptor antagonist
Hyponatremia
Pituitary
Surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402202254X

Internet

http://www.sciencedirect.com/science/article/pii/S240584402202254X

Similar Items